News | May 21, 2008

Researchers Recognized for MRI for Atrial Fibrillation Technique

May 22, 2008 - Nassir Marrouche, M.D., and his research team from the University of Utah School of Medicine received the Eric N. Prystowsky Fellow Clinical Research award for their abstract on experimental studies showing how magnetic resonance imaging (MRI) angiograms can be effectively used during atrial fibrillation (AF) procedures.

The award was presented at Heart Rhythm 2008, held in San Francisco, May 14-17. The winning entry from Dr. Marrouche, Dr. Marcos Daccarett and their colleagues was an abstract entitled, “Quantitative Measurement and Three Dimensional Visualization of Scar Formation Following Pulmonary Vein Isolation for Atrial Fibrillation.”

“We appreciate this honor and are proud to be the first program in the country to focus on refining image-based heart ablation procedures using MRI,” said Dr. Marrouche, the director of the Atrial Fibrillation Program at the University of Utah School of Medicine.

Treatment of AF often involves radiofrequency (RF) ablation, a procedure in which the electrical signals that cause the heart to contract at a chaotic, usually rapid rate are mapped, localized, and then destroyed (i.e., ablated) using RF energy. Since MRI offers the most detailed information about normal and damaged myocardial tissue, Dr. Marrouche is investigating its use in patient screening, procedure planning, procedure navigation and localizing the causes of post-procedural complications.

The purpose of his research is to improve the curative rates and safety of RF ablation procedures. At the American College of Cardiology conference earlier this year, he presented the first study to show how MRI can be used as a precise, pre-procedure diagnostic tool to visually demonstrate AF’s progression and location. And last October, the University of Utah AF program became the first in the world to be able to ablate using a catheter custom-made to be compatible with MRI.

Dr. Marrouche has performed more than 1,000 ablation procedures, and about 90% of his patients are arrhythmia free and off heart medications within three months of their procedures. Their major complication rates are less than 0.5%, more 12 times better than the comparable 6% rate in a 2005 worldwide survey of the ablation procedure outcomes.

The Heart Rhythm Society's Eric N. Prystowsky Fellow Clinical Research award is given to the top three highest scoring abstracts submitted to the Clinical Electrophysiology, Catheter Ablation or Devices categories.

For more information: www.hrsonline.org

Related Content

ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Magnetic Resonance Imaging (MRI)| August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
GE Healthcare's Signa Premier MRI Receives FDA 510(k) Clearance
Technology | Magnetic Resonance Imaging (MRI)| August 04, 2017
GE Healthcare announced Signa Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available...
Cardiac CT scan showing plaque and calcification in the coronary arteries, from a Toshiba CT scanner
News | Business| July 19, 2017
July 19, 2017 — The Society of Cardiovascular Computed Tomography (SCCT) created a reimbursement fee chart for cardia
German Workshop Highlights Possibilities of Perfusion MRI
News | Stroke| July 03, 2017
When diagnosing strokes and heart diseases or looking at tumors, perfusion magnetic resonance imaging (MRI) offers a...
Sponsored Content | Videos | Clinical Decision Support| June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
Toshiba Medical Introduces Vantage Titan Zen Edition MR
Technology | Magnetic Resonance Imaging (MRI)| June 27, 2017
June 27, 2017 — Toshiba Medical, a Canon Group company, introduced its newest...
HRS released a consensus statement on MRI for patients with cardiac implantable electronic devices
Feature | May 15, 2017
May 15, 2017 — The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement in the United States o
Biotronik Launches First FDA-Approved CRM Devices with MRI AutoDetect Technology
Technology | Cardiac Resynchronization Therapy Devices (CRT)| May 10, 2017
Biotronik announced the availability of the first U.S. Food and Drug Administration (FDA)-approved cardiac rhythm...
Toshiba Showcases Vantage Galan 3T MRI at ISMRM 2017
News | Magnetic Resonance Imaging (MRI)| April 24, 2017
April 24, 2017 — Offering a full range of advanced clinical applications for researchers, Toshiba Medical will demons
Overlay Init